Advances in therapies and imaging for systemic vasculitis
Vasculitis is a systemic disease characterized by immune-mediated injury of blood vessels.
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Advances in Therapies and Imaging for Systemic Vasculitis
TE Farrah, N Basu, M Dweck, C Calcagno… - Arteriosclerosis …, 2019 - research.ed.ac.uk
Vasculitis is a systemic disease characterized by immune-mediated injury of blood vessels.
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
[PDF][PDF] Advances in Therapies and Imaging for Systemic Vasculitis
TE Farrah, N Basu, M Dweck, C Calcagno… - … Thromb Vasc Biol, 2019 - core.ac.uk
Vasculitis is a systemic disease characterized by immune-mediated injury of blood vessels.
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
[PDF][PDF] Advances in Therapies and Imaging for Systemic Vasculitis
TE Farrah, N Basu, M Dweck, C Calcagno, ZA Fayad… - management, 2019 - pure.ed.ac.uk
Vasculitis is a systemic disease characterized by immune-mediated injury of blood vessels.
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Advances in Therapies and Imaging for Systemic Vasculitis.
TE Farrah, N Basu, M Dweck, C Calcagno… - … and Vascular Biology, 2019 - europepmc.org
Vasculitis is a systemic disease characterized by immune-mediated injury of blood vessels.
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
[PDF][PDF] Advances in Therapies and Imaging for Systemic Vasculitis
TE Farrah, N Basu, M Dweck, C Calcagno… - … Thromb Vasc Biol, 2019 - researchgate.net
Vasculitis is a systemic disease characterized by immune-mediated injury of blood vessels.
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Advances in Therapies and Imaging for Systemic Vasculitis
TE Farrah, N Basu, M Dweck, C Calcagno… - … , and Vascular Biology, 2019 - cir.nii.ac.jp
抄録< jats: p> Vasculitis is a systemic disease characterized by immune-mediated injury of
blood vessels. Current treatments for vasculitis, such as glucocorticoids and alkylating …
blood vessels. Current treatments for vasculitis, such as glucocorticoids and alkylating …
[PDF][PDF] Advances in Therapies and Imaging for Systemic Vasculitis
TE Farrah, N Basu, M Dweck… - … Thromb Vasc Biol, 2019 - scholar.archive.org
Vasculitis is a systemic disease characterized by immune-mediated injury of blood vessels.
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Advances in Therapies and Imaging for Systemic Vasculitis
TE Farrah, N Basu, M Dweck… - Arteriosclerosis …, 2019 - pubmed.ncbi.nlm.nih.gov
Vasculitis is a systemic disease characterized by immune-mediated injury of blood vessels.
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Advances in therapies and imaging for systemic vasculitis
TE Farrah, N Basu, M Dweck, C Calcagno… - … and Vascular Biology, 2019 - eprints.gla.ac.uk
Vasculitis is a systemic disease characterized by immune-mediated injury of blood vessels.
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …
Current treatments for vasculitis, such as glucocorticoids and alkylating agents, are …